Michael B. Fowler

25.2k total citations · 7 hit papers
139 papers, 17.2k citations indexed

About

Michael B. Fowler is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Biomedical Engineering. According to data from OpenAlex, Michael B. Fowler has authored 139 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Cardiology and Cardiovascular Medicine, 29 papers in Surgery and 16 papers in Biomedical Engineering. Recurrent topics in Michael B. Fowler's work include Heart Failure Treatment and Management (58 papers), Cardiovascular Function and Risk Factors (28 papers) and Cardiac pacing and defibrillation studies (26 papers). Michael B. Fowler is often cited by papers focused on Heart Failure Treatment and Management (58 papers), Cardiovascular Function and Risk Factors (28 papers) and Cardiac pacing and defibrillation studies (26 papers). Michael B. Fowler collaborates with scholars based in United States, United Kingdom and Australia. Michael B. Fowler's co-authors include Michael R. Bristow, Milton Packer, Andrew J.S. Coats, Edward M. Gilbert, Wilson S. Colucci, Jay N. Cohn, Neil H. Shusterman, Milton Packer, Hugo A. Katus and Michał Tendera and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Michael B. Fowler

130 papers receiving 16.3k citations

Hit Papers

The Effect of Carvedilol on Morbidity and Mortality in Pa... 1986 2026 1999 2012 1996 2001 2001 1986 2002 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
    1996 3.4k citations Milton Packer, Michael R. Bristow et al. profile →
  2. Effect of Carvedilol on Survival in Severe Chronic Heart Failure
    2001 2.2k citations Milton Packer, Andrew J.S. Coats et al. profile →
  3. Effect of carvedilol on survival in severe chronic heart failure
    2001 1.3k citations Milton Packer, Andrew J.S. Coats et al. profile →
  4. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
    1986 1.0k citations Michael R. Bristow, Michael B. Fowler et al. profile →
  5. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure
    2002 928 citations Milton Packer, Michael B. Fowler et al. profile →
  6. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
    1993 902 citations Michael R. Bristow, Edward M. Gilbert et al. profile →
  7. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response.
    1986 431 citations Michael B. Fowler, Michael R. Bristow et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael B. Fowler United States 47 13.9k 2.4k 2.3k 1.6k 1.2k 139 17.2k
Chim C. Lang United Kingdom 65 8.8k 0.6× 2.6k 1.1× 2.3k 1.0× 1.7k 1.1× 3.0k 2.4× 394 16.1k
Wiek H. van Gilst Netherlands 68 11.8k 0.8× 2.8k 1.2× 3.6k 1.6× 1.4k 0.9× 2.4k 2.0× 475 20.4k
Inder S. Anand United States 81 17.6k 1.3× 2.9k 1.2× 1.6k 0.7× 3.0k 1.9× 2.7k 2.2× 420 23.2k
Giuseppe Schillaci Italy 62 11.7k 0.8× 2.7k 1.1× 960 0.4× 1.6k 1.0× 2.3k 1.8× 217 16.4k
Robert Cody United States 43 13.0k 0.9× 2.9k 1.2× 1.9k 0.8× 3.3k 2.1× 4.3k 3.5× 153 17.4k
Kirkwood F. Adams United States 59 11.8k 0.8× 1.6k 0.7× 1.3k 0.5× 3.0k 1.9× 1000 0.8× 214 15.1k
Javed Butler United States 59 11.4k 0.8× 2.1k 0.9× 2.2k 0.9× 2.4k 1.6× 2.7k 2.2× 406 16.0k
William W. Parmley United States 68 11.8k 0.9× 3.9k 1.6× 1.5k 0.7× 1.1k 0.7× 928 0.8× 343 15.9k
Mihai Gheorghiade United States 63 13.5k 1.0× 2.1k 0.9× 1.3k 0.5× 3.5k 2.2× 1.2k 1.0× 205 16.7k
Edward M. Gilbert United States 45 9.9k 0.7× 2.2k 0.9× 1.7k 0.7× 765 0.5× 571 0.5× 156 12.1k

Countries citing papers authored by Michael B. Fowler

Since Specialization
Citations

This map shows the geographic impact of Michael B. Fowler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael B. Fowler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael B. Fowler more than expected).

Fields of papers citing papers by Michael B. Fowler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael B. Fowler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael B. Fowler. The network helps show where Michael B. Fowler may publish in the future.

Co-authorship network of co-authors of Michael B. Fowler

This figure shows the co-authorship network connecting the top 25 collaborators of Michael B. Fowler. A scholar is included among the top collaborators of Michael B. Fowler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael B. Fowler. Michael B. Fowler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrett, Christopher D., Michaela Liedtke, Mirela Tuzovic, et al.. (2019). A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis. JACC Heart Failure. 7(11). 958–966. 34 indexed citations
2.
Guo, H. Henry, et al.. (2018). SERIAL CARDIAC FDG-PET IN THE DIAGNOSIS AND THERAPEUTIC GUIDANCE OF PATIENTS WITH CARDIAC SARCOIDOSIS: A STANFORD EXPERIENCE. Journal of the American College of Cardiology. 71(11). A1690–A1690.
3.
Greenberg, Barry, Jeanenne J. Nelson, Mary Ann Lukas, et al.. (2006). Predictors of Clinical Outcomes in Patients Given Carvedilol for Heart Failure. The American Journal of Cardiology. 98(11). 1480–1484. 5 indexed citations
4.
DeBusk, Robert F., Nancy Houston Miller, Kathleen M. Parker, et al.. (2004). Care Management for Low-Risk Patients with Heart Failure. Annals of Internal Medicine. 10 indexed citations
5.
Hartmann, Franz, Milton Packer, Andrew J.S. Coats, et al.. (2004). NT-proBNP in Severe Chronic Heart Failure: Rationale, Design and Preliminary Results of the COPERNICUS NT-proBNP Substudy. European Journal of Heart Failure. 6(3). 343–350. 74 indexed citations
6.
Witteles, Ronald, et al.. (2004). Insulin resistance in idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 44(1). 78–81. 94 indexed citations
7.
Rouleau, Jean L., Ellen B. Roecker, Michał Tendera, et al.. (2004). Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure. Journal of the American College of Cardiology. 43(8). 1423–1429. 108 indexed citations
8.
Fowler, Michael B., Jeanenne J. Nelson, Mary Ann Lukas, et al.. (2004). 821-3 Evaluation of beta-blocker does in community-based treatment of heart failure. Journal of the American College of Cardiology. 43(5). A196–A196. 1 indexed citations
9.
Witteles, Ronald, et al.. (2002). High prevalence of impaired glucose metabolism in patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 39. 181–181. 1 indexed citations
10.
Vagelos, Randall H., et al.. (2002). Reverse remodeling following long-term carvedilol therapy is associated with improvement in survival: the stanford carvedilol echocardiographic registry. Journal of the American College of Cardiology. 39. 141–141. 2 indexed citations
11.
Fowler, Michael B., Montserrat Vera‐Llonch, Gerry Oster, et al.. (2001). Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. Journal of the American College of Cardiology. 37(6). 1692–1699. 53 indexed citations
12.
Gullestad, Lars, Pål Aukrust, Thor Ueland, et al.. (1999). Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. Journal of the American College of Cardiology. 34(7). 2061–2067. 193 indexed citations
13.
Cohn, Jay N., Michael B. Fowler, Wilson S. Colucci, et al.. (1996). Effect of carvedilol in severe chronic heart failure. Journal of the American College of Cardiology. 27(2). 169–169. 24 indexed citations
14.
Rickenbacher, Peter, Pedro T. Trindade, Guy A. Haywood, et al.. (1996). Transplant candidates with severe left ventricular dysfunction managed with medical treatment: Characteristics and survival. Journal of the American College of Cardiology. 27(5). 1192–1197. 55 indexed citations
15.
Fifer, Michael A., César Molina, Antonio C. Quiroz, et al.. (1990). Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. The American Journal of Cardiology. 65(3). 211–216. 58 indexed citations
16.
Molina, César, et al.. (1988). Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. Journal of the American College of Cardiology. 12(1). 175–186. 84 indexed citations
17.
Holt, D W, et al.. (1982). High performance liquid chromatographic measurement of atenolol placental transfer and expression in breast milk. British Journal of Clinical Pharmacology. 14(1). 148–149. 5 indexed citations
18.
Timmis, Adam, Michael B. Fowler, & D. A. Chamberlain. (1981). Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction.. BMJ. 282(6257). 7–9. 17 indexed citations
19.
Fowler, Michael B., Adam Timmis, & D. A. Chamberlain. (1980). Synergistic effects of a combined salbutamol-nitroprusside regimen in acute myocardial infarction and severe left ventricular failure.. BMJ. 280(6212). 435–437. 4 indexed citations
20.
Fowler, Michael B., et al.. (1965). Acute Pyogenic Meningitis Probably Due to Acanthamoeba sp.: a Preliminary Report. BMJ. 2(5464). 734.2–742. 269 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chim C. Lang Breakdown of academic impact, for papers by Wiek H. van Gilst Breakdown of academic impact, for papers by Inder S. Anand Breakdown of academic impact, for papers by Giuseppe Schillaci Breakdown of academic impact, for papers by Robert Cody Breakdown of academic impact, for papers by Kirkwood F. Adams Breakdown of academic impact, for papers by Javed Butler Breakdown of academic impact, for papers by William W. Parmley Breakdown of academic impact, for papers by Mihai Gheorghiade Breakdown of academic impact, for papers by Edward M. Gilbert
Rankless by CCL
2026